FK506 is an immunosuppressive drug that inhibits the phosphatase activity of calcineurin, thereby interfering with normal signal transduction pathways. In an Advanced Online Publication in Nature Cell Biology Shirane and Nakayama from Kyushu University in Japan, describe a role for the mitochondrial FK506-binding protein 38 (FKBP38) in preventing apoptosis (Nature Cell Biology, 23 December 2002, DOI:10.1038/ncb894). They fished out FKBP38 in a yeast two-hybrid screen for Bcl-2-interacting proteins. FKBP38 co-immunoprecipitates with Bcl-2 and the related Bcl-XL protein. It also interacts with calcineurin, in a FK506-independent manner, and inhibits its phosphatase activity. FKBP38 regulates the cellular localization of Bcl-2 and Bcl-XL, targeting them to the mitochondria and preventing apoptosis.
References
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.
Nature Cell Biology, [http://www.nature.com/naturecellbiology]
Kyushu University, [http://www.kyushu-u.ac.jp/english/index-e.htm]
Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs.
Rights and permissions
About this article
Cite this article
Weitzman, J.B. Natural calcineurin inhibitor. Genome Biol 4, spotlight-20030103-01 (2003). https://doi.org/10.1186/gb-spotlight-20030103-01
Published:
DOI: https://doi.org/10.1186/gb-spotlight-20030103-01